bluebird bio And 2seventy bio - Spinner And Spun: The Better Bet In Cell Therapy [Seeking Alpha]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Seeking Alpha
Bluebird has a longer history as a public company and has established itself as a gene therapy leader with FDA-approved therapies. Both companies are facing financial difficulties, but Bluebird has a more promising pipeline of FDA-approved gene therapies. This is my first look at a pair of cell therapy hopefuls, bluebird bio ( NASDAQ: BLUE ) and 2seventy bio ( NASDAQ: TSVT ); the two have several FDA approved cell therapies with PDUFAs pending for both. In this article I report how these two small biotechs are struggling as they punch well above their weight in the challenging field of cell therapies. Now that the deal has closed and both have an operational history as independent companies, this article assesses the situation. It identifies which of the two, bluebird - spinner or 2seventy - spun, is a better investment bet as I write on 09/14/23. To be sure these are not the halcyon days for gene therapy. Those days are best exemplified by: Gilead's ( GILD ) 08/2017 $11.9
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever [Yahoo! Finance]Yahoo! Finance
- Global Healthy Living Foundation Expands Access to Education and Clinical Trial Information for Spanish-Speaking Lupus Communities [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb: A Pharma Giant Trading Like Growth Is Over - It's Not [Seeking Alpha]Seeking Alpha
- Is Bristol Myers Squibb (BMY) Still Undervalued After Its Recent Share Price Rebound? [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers (BMY) Offers Eliquis Free to Medicaid Patients Under New Pricing Pact [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 10/31/25 - Beat
BMY
Sec Filings
- 11/18/25 - Form 8-K
- 11/12/25 - Form CERT
- 11/10/25 - Form 8-A12B
- BMY's page on the SEC website